Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Metabolomics | 9 | 2023 | 1628 | 1.260 |
Why?
|
Peripartum Period | 2 | 2015 | 138 | 0.900 |
Why?
|
Cardiomyopathies | 3 | 2024 | 1952 | 0.830 |
Why?
|
Penetrance | 1 | 2024 | 388 | 0.820 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2015 | 516 | 0.710 |
Why?
|
Proteomics | 8 | 2024 | 3817 | 0.660 |
Why?
|
Embolectomy | 1 | 2019 | 129 | 0.640 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2021 | 854 | 0.630 |
Why?
|
Eating | 1 | 2024 | 1539 | 0.570 |
Why?
|
Genome-Wide Association Study | 5 | 2024 | 12626 | 0.540 |
Why?
|
Metformin | 1 | 2024 | 912 | 0.530 |
Why?
|
Recovery of Function | 2 | 2015 | 2985 | 0.470 |
Why?
|
Cardiovascular Diseases | 6 | 2023 | 15757 | 0.460 |
Why?
|
Proteome | 6 | 2023 | 1855 | 0.440 |
Why?
|
Body Weight | 1 | 2024 | 4611 | 0.430 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2021 | 1717 | 0.390 |
Why?
|
Genetic Testing | 1 | 2024 | 3531 | 0.370 |
Why?
|
Drug-Eluting Stents | 1 | 2017 | 757 | 0.360 |
Why?
|
Echocardiography | 2 | 2021 | 4981 | 0.350 |
Why?
|
Coronary Disease | 2 | 2022 | 5990 | 0.340 |
Why?
|
Blood Proteins | 3 | 2024 | 1173 | 0.330 |
Why?
|
Phenotype | 5 | 2024 | 16546 | 0.330 |
Why?
|
Heart Failure | 4 | 2022 | 11847 | 0.330 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2019 | 1459 | 0.310 |
Why?
|
C-Reactive Protein | 1 | 2019 | 3839 | 0.290 |
Why?
|
Electronic Health Records | 1 | 2024 | 4775 | 0.280 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2543 | 0.270 |
Why?
|
Quantitative Trait Loci | 2 | 2024 | 2101 | 0.250 |
Why?
|
Phenylalanine | 2 | 2024 | 365 | 0.250 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 3201 | 0.230 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2024 | 1311 | 0.230 |
Why?
|
Genomics | 1 | 2020 | 5794 | 0.230 |
Why?
|
Oleic Acids | 1 | 2023 | 74 | 0.210 |
Why?
|
Sickle Cell Trait | 1 | 2023 | 85 | 0.210 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 12293 | 0.200 |
Why?
|
Dipeptides | 1 | 2024 | 409 | 0.200 |
Why?
|
Metabolome | 3 | 2023 | 982 | 0.190 |
Why?
|
Homoarginine | 1 | 2021 | 9 | 0.190 |
Why?
|
Orotic Acid | 1 | 2021 | 24 | 0.190 |
Why?
|
Chemokine CX3CL1 | 1 | 2021 | 64 | 0.190 |
Why?
|
Spermine | 1 | 2021 | 69 | 0.190 |
Why?
|
Risk Assessment | 5 | 2024 | 24123 | 0.180 |
Why?
|
Uridine | 1 | 2021 | 143 | 0.180 |
Why?
|
Polyamines | 1 | 2021 | 133 | 0.180 |
Why?
|
Respiration Disorders | 1 | 2023 | 368 | 0.170 |
Why?
|
Proline | 1 | 2021 | 457 | 0.160 |
Why?
|
Humans | 37 | 2024 | 760621 | 0.160 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2021 | 415 | 0.150 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 6659 | 0.150 |
Why?
|
Renal Insufficiency | 1 | 2023 | 820 | 0.140 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2021 | 479 | 0.140 |
Why?
|
Amino Acids | 1 | 2023 | 1714 | 0.140 |
Why?
|
Glycolysis | 1 | 2021 | 828 | 0.140 |
Why?
|
Pacemaker, Artificial | 1 | 2022 | 815 | 0.130 |
Why?
|
Tandem Mass Spectrometry | 1 | 2022 | 1189 | 0.130 |
Why?
|
Death, Sudden, Cardiac | 1 | 2024 | 1572 | 0.130 |
Why?
|
Hypertension | 2 | 2024 | 8594 | 0.120 |
Why?
|
Models, Genetic | 1 | 2024 | 3442 | 0.110 |
Why?
|
Sinusitis | 1 | 2023 | 990 | 0.110 |
Why?
|
Exercise | 3 | 2024 | 5787 | 0.110 |
Why?
|
Collagen | 1 | 2021 | 2636 | 0.100 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1657 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2021 | 2141 | 0.100 |
Why?
|
Incidence | 4 | 2024 | 21392 | 0.090 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3150 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2022 | 14495 | 0.090 |
Why?
|
Stroke Volume | 2 | 2022 | 5523 | 0.090 |
Why?
|
Male | 13 | 2024 | 359744 | 0.090 |
Why?
|
Proportional Hazards Models | 2 | 2022 | 12531 | 0.080 |
Why?
|
Middle Aged | 10 | 2024 | 220352 | 0.080 |
Why?
|
Female | 13 | 2024 | 391270 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6828 | 0.080 |
Why?
|
Aged | 7 | 2024 | 169152 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9631 | 0.080 |
Why?
|
Blood Pressure | 1 | 2024 | 8525 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 3016 | 0.080 |
Why?
|
Adult | 9 | 2024 | 219994 | 0.080 |
Why?
|
Blood Glucose | 1 | 2022 | 6381 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3224 | 0.070 |
Why?
|
Computational Biology | 1 | 2020 | 3505 | 0.070 |
Why?
|
Survival Rate | 1 | 2019 | 12808 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2021 | 3517 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5209 | 0.060 |
Why?
|
Time Factors | 2 | 2017 | 40165 | 0.060 |
Why?
|
Mice | 4 | 2024 | 81208 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5889 | 0.060 |
Why?
|
Asthma | 1 | 2023 | 6172 | 0.060 |
Why?
|
Cohort Studies | 4 | 2023 | 41335 | 0.060 |
Why?
|
Risk Factors | 4 | 2023 | 74359 | 0.050 |
Why?
|
Thrombosis | 1 | 2017 | 3052 | 0.050 |
Why?
|
Pregnancy | 2 | 2015 | 29749 | 0.050 |
Why?
|
Young Adult | 2 | 2023 | 58741 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2021 | 22053 | 0.050 |
Why?
|
Aptamers, Peptide | 1 | 2022 | 28 | 0.050 |
Why?
|
Diet | 1 | 2021 | 8010 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 17790 | 0.050 |
Why?
|
Mutation | 2 | 2024 | 29932 | 0.050 |
Why?
|
Leucine | 1 | 2023 | 547 | 0.050 |
Why?
|
Fish Products | 1 | 2021 | 29 | 0.050 |
Why?
|
Hemolysis | 1 | 2023 | 423 | 0.050 |
Why?
|
Mississippi | 1 | 2021 | 93 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2023 | 371 | 0.050 |
Why?
|
Meat Products | 1 | 2021 | 96 | 0.050 |
Why?
|
Ischemic Preconditioning | 1 | 2021 | 89 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10344 | 0.040 |
Why?
|
Cystatin C | 1 | 2021 | 270 | 0.040 |
Why?
|
Plasma | 1 | 2023 | 584 | 0.040 |
Why?
|
Carnitine | 1 | 2021 | 252 | 0.040 |
Why?
|
Mitochondria, Heart | 1 | 2021 | 229 | 0.040 |
Why?
|
Animals | 4 | 2024 | 167963 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2024 | 2932 | 0.040 |
Why?
|
Interleukin-10 | 1 | 2023 | 1175 | 0.040 |
Why?
|
Immunity | 1 | 2023 | 998 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 789 | 0.030 |
Why?
|
Exercise Test | 1 | 2024 | 2128 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2023 | 1296 | 0.030 |
Why?
|
Lactic Acid | 1 | 2021 | 1134 | 0.030 |
Why?
|
Vegetables | 1 | 2021 | 1196 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 65017 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1804 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1261 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2021 | 1843 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2061 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2421 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2023 | 15789 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10756 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2014 | 11891 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22023 | 0.030 |
Why?
|
Internet | 1 | 2023 | 3078 | 0.020 |
Why?
|
Computer Simulation | 1 | 2024 | 6218 | 0.020 |
Why?
|
Phosphorylation | 1 | 2021 | 8313 | 0.020 |
Why?
|
Life Style | 1 | 2021 | 3896 | 0.020 |
Why?
|
Health Behavior | 1 | 2021 | 2622 | 0.020 |
Why?
|
Oxygen | 1 | 2021 | 4193 | 0.020 |
Why?
|
Signal Transduction | 2 | 2023 | 23376 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4351 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5125 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4925 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9287 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4897 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 8035 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10547 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13502 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2015 | 80372 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 9073 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2014 | 1958 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 18957 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20080 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23711 | 0.010 |
Why?
|
United States | 2 | 2023 | 72461 | 0.010 |
Why?
|
Algorithms | 1 | 2024 | 13981 | 0.010 |
Why?
|
Prognosis | 1 | 2023 | 29658 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12922 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25942 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54303 | 0.010 |
Why?
|
Registries | 1 | 2014 | 8469 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2014 | 58995 | 0.010 |
Why?
|
Concepts
(157)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_